Retatrutide is an innovative glucagon-like peptide-1 receptor agonist. This drug has shown potential in treating type 2 diabetes. By mimicking the actions of naturally occurring GLP-1, Retatrutide enhances insulin https://hassannwrb040353.wikicorrespondence.com/user